DIABETES TECHNOLOGY & THERAPEUTICS Journal
Overview
publication venue for
- Statistically Adjusting for Wear Time in Randomized Trials of Continuous Glucose Monitors as a Complement to Intent-to-Treat and As-Treated Analyses: Application and Evaluation in Two Trials 2023
- Relationship Between Moderate-to-Vigorous Physical Activity and Glycemia Among Young Adults with Type 1 Diabetes and Overweight or Obesity: Results from the Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON) Study. 24:881-891. 2022
- Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes 2022
- STRONG TREATMENT EFFECT OF CONTINUOUS GLUCOSE MONITORING (CGM) IN REDUCING HYPOGLYCEMIA IRRESPECTIVE OF PREVIOUS BLOOD GLUCOSE MONITORING AMONG OLDER ADULTS WITH TYPE 1 DIABETES (T1D) 2021
- BENEFIT OF CONTINUOUS GLUCOSE MONITORING (CGM) IN REDUCING HYPOGLYCEMIA IS SUSTAINED THROUGH 12 MONTHS OF USE AMONG OLDER ADULTS WITH TYPE 1 DIABETES (T1D) 2020
- EFFICACY OF ORAL SEMAGLUTIDE ACCORDING TO DIABETES DURATION: AN EXPLORATORY SUBGROUP ANALYSIS OF THE PIONEER TRIAL PROGRAMME 2020
- OLDER ADULTS WITH TYPE 1 DIABETES DEMONSTRATE HIGH UTILIZATION OF CGM AND HIGH CONFIDENCE IN CGM DATA 2020
- Should GLP-1 Receptor Agonists Be the First Line of Treatment for Type 2 Diabetes? 2016
- Changes in Insulin Sensitivity and Insulin Secretion with the Sodium Glucose Cotransporter 2 Inhibitor Dapagliflozin. 16:137-144. 2014
- Total energy expenditure estimated using foot-ground contact pedometry. 2004
Research
category
- ENDOCRINOLOGY & METABOLISM Web of Science Category
Identity
International Standard Serial Number (ISSN)
- 1520-9156
Electronic International Standard Serial Number (EISSN)
- 1557-8593
Other
journal abbreviation
- DIABETES TECHNOL THE
- Diabetes Technol Ther